InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.92
(
0.15%
)
Bitcoin
65,098.11
(
-0.06%
)
Post# of 1194
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Amatuer17

Send PM Follow Ignore
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Amatuer17

Re: Bio7mm post# 960

Thursday, 04/14/2016 2:51:35 PM

Thursday, April 14, 2016 2:51:35 PM

Post# of 1194
MBVX is a very interesting company.

Many of the new drugs use monoclonal antibodies and humanized antibodies have lowest toxicity.

MBVX has proprietary rights to some 100 such mAb - which is huge.

However the big issue is funding and timeline to test each of them - not sure how company will survive.
Some pharma co with right intentin can just buy the co for access to man.

Read some very detailed article in SA on this company

MabVax: An Underappreciated Cancer Immunotherapy Play $MBVX
http://www.seekingalpha.com/article/3325165

The Real Value In MabVax May Be Partnerships Rather Than Pipeline $MBVX
http://www.seekingalpha.com/article/3105416
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up